Variant report

Variant	nsv1026368
Chromosome Location	chr6:15027130-15063790
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:79)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:79 , 50 per page) page: 1 2

No.	Distal block	Cell Line	Cell type
1	chr6:15036408..15038613-chr6:15244258..15245981,2	K562	blood:
2	chr17:65373335..65375372-chr6:15035832..15038748,2	MCF-7	breast:
3	chr6:14889597..14891990-chr6:15061362..15063428,2	K562	blood:
4	chr6:15045609..15048317-chr6:15050258..15052643,2	MCF-7	breast:
5	chr6:14732758..14733847-chr6:15036623..15037413,3	MCF-7	breast:
6	chr6:15016484..15018305-chr6:15062981..15064524,2	K562	blood:
7	chr6:15026938..15027776-chr6:15221914..15222444,2	MCF-7	breast:
8	chr6:15034432..15037306-chr6:15044594..15046139,2	MCF-7	breast:
9	chr6:15036807..15037626-chr6:15065967..15066594,2	MCF-7	breast:
10	chr6:15036654..15037849-chr6:15221676..15222733,18	MCF-7	breast:
11	chr6:15014025..15014906-chr6:15036946..15037491,2	MCF-7	breast:
12	chr6:15036661..15037447-chr6:15159692..15160578,4	MCF-7	breast:
13	chr6:15036573..15037548-chr6:15089967..15091218,7	MCF-7	breast:
14	chr6:15023186..15025452-chr6:15025513..15027859,2	MCF-7	breast:
15	chr6:15063509..15068597-chr6:15242568..15250230,12	MCF-7	breast:
16	chr6:15062443..15064053-chr6:15088661..15091541,2	K562	blood:
17	chr6:15062744..15064596-chr6:15064785..15067869,4	K562	blood:
18	chr6:14731441..14733331-chr6:15038049..15039604,2	MCF-7	breast:
19	chr6:14758426..14758937-chr6:15036812..15037561,2	MCF-7	breast:
20	chr6:15061827..15065588-chr6:15088079..15090831,5	K562	blood:
21	chr6:15041630..15044094-chr6:15245777..15248149,2	MCF-7	breast:
22	chr6:15063403..15067702-chr6:15220647..15223786,6	MCF-7	breast:
23	chr6:15058764..15061623-chr6:15064836..15067219,2	K562	blood:
24	chr6:15036661..15037725-chr6:15159629..15160578,6	MCF-7	breast:
25	chr6:15036541..15037680-chr6:15221576..15222858,87	MCF-7	breast:
26	chr6:15035898..15040571-chr6:15245085..15252614,13	MCF-7	breast:
27	chr6:15035801..15039446-chr6:15245736..15248924,6	MCF-7	breast:
28	chr6:14952333..14954050-chr6:15035656..15038641,2	MCF-7	breast:
29	chr6:14984557..14985061-chr6:15036553..15037285,2	MCF-7	breast:
30	chr6:15036618..15037814-chr6:15222040..15222792,3	MCF-7	breast:
31	chr6:15019075..15021891-chr6:15031714..15033767,2	K562	blood:
32	chr6:15036988..15039713-chr6:15046877..15049842,3	K562	blood:
33	chr6:15045470..15047260-chr6:15051522..15053557,2	K562	blood:
34	chr6:15034583..15040875-chr6:15061503..15068528,12	MCF-7	breast:
35	chr6:14733035..14733847-chr6:15036623..15037413,2	MCF-7	breast:
36	chr6:15036574..15037506-chr6:15079164..15079879,3	MCF-7	breast:
37	chr6:15034583..15040875-chr6:15061503..15068528,12	MCF-7	breast:
38	chr6:14733830..14736218-chr6:15031394..15034242,2	MCF-7	breast:
39	chr6:15041823..15046461-chr6:15048611..15051361,4	K562	blood:
40	chr6:15036656..15037616-chr6:15251384..15252228,3	MCF-7	breast:
41	chr6:15061013..15064608-chr6:15244095..15248960,6	K562	blood:
42	chr6:15022607..15023116-chr6:15036750..15037271,2	MCF-7	breast:
43	chr6:15028790..15031213-chr6:15245800..15247832,3	MCF-7	breast:
44	chr6:15044233..15047661-chr6:15048206..15054228,7	K562	blood:
45	chr6:15036988..15039713-chr6:15046877..15049842,3	K562	blood:
46	chr6:15028717..15030256-chr6:15247473..15249363,2	K562	blood:
47	chr6:15039064..15039957-chr6:15078965..15079525,2	MCF-7	breast:
48	chr6:15034993..15036710-chr6:15070222..15072804,2	MCF-7	breast:
49	chr6:15060990..15063217-chr6:15088088..15090210,2	MCF-7	breast:
50	chr6:15039064..15039694-chr6:15090359..15090972,2	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DTNBP1-5	chr6:15053131-15053417	NONHSAT107859

No data

Variant related genes	Relation type
ENSG00000271888	chromatin interactions
ENSG00000234261	chromatin interactions
ENSG00000235488	chromatin interactions
ENSG00000154217	chromatin interactions
ENSG00000008083	chromatin interactions

Extended variants
information (count: 1474 )
Associated
traits (count: 96 )

Variant overlapped rSNPs/rCNVs (count:1474 , 50 per page) page: 1 2 3 4 5 6 7 ... 30

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs16876035	chr6:15027130-15027131	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs375914411	chr6:15027147-15027148	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs191942544	chr6:15027148-15027149	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs181085309	chr6:15027175-15027176	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs555090499	chr6:15027200-15027201	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs73724703	chr6:15027229-15027230	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs373150766	chr6:15027267-15027268	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs6916705	chr6:15027286-15027287	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs570864228	chr6:15027287-15027288	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs144962832	chr6:15027304-15027305	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs140929710	chr6:15027320-15027321	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs533749021	chr6:15027377-15027378	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs553517877	chr6:15027382-15027383	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs573876558	chr6:15027398-15027399	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs542938517	chr6:15027424-15027425	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs562627860	chr6:15027450-15027451	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs112449825	chr6:15027546-15027547	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs185878120	chr6:15027549-15027550	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs544275128	chr6:15027582-15027583	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs548306047	chr6:15027605-15027606	Weak transcription Enhancers Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs564572253	chr6:15027613-15027614	Weak transcription Enhancers Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs533423481	chr6:15027665-15027666	Weak transcription Enhancers Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs144581684	chr6:15027679-15027680	Weak transcription Enhancers Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs191570837	chr6:15027741-15027742	Weak transcription Enhancers Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs529443518	chr6:15027779-15027780	Weak transcription Enhancers Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs73724704	chr6:15027791-15027792	Weak transcription Enhancers Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs115605000	chr6:15027796-15027797	Weak transcription Enhancers Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs12055480	chr6:15027805-15027806	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs550922742	chr6:15027836-15027837	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs114530130	chr6:15027846-15027847	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs533571300	chr6:15027891-15027892	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs553431760	chr6:15027924-15027925	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs573817066	chr6:15027933-15027934	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs539912238	chr6:15027954-15027955	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs553716768	chr6:15028004-15028005	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs183053299	chr6:15028010-15028011	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs185348966	chr6:15028012-15028013	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs373925085	chr6:15028024-15028025	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs576208269	chr6:15028034-15028035	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs75344985	chr6:15028036-15028037	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs564438594	chr6:15028060-15028061	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs61050615	chr6:15028075-15028076	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs75316053	chr6:15028124-15028125	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs190503995	chr6:15028205-15028206	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs141802493	chr6:15028206-15028207	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs182740320	chr6:15028236-15028237	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs73724705	chr6:15028254-15028255	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs61576447	chr6:15028255-15028256	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs550986147	chr6:15028272-15028273	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs575381121	chr6:15028279-15028280	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:96)

Disease	PMID	Source
Cancer	20164920	CNVD
Colorectal cancer	21297112	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Myelodysplastic syndrome	21251322	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Multiple myeloma	17550852	CNVD
Ewing''s sarcoma	17952124	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
small cell lung cancer	20016488	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Osteosarcoma	16790693	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Ovarian cancer	21720365	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Bladder cancer	21909424	CNVD
Burkitt''s lymphoma	19759907	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Hodgkin''s lymphoma	17606441	CNVD
abnormal development	18461090	CNVD
Cancer	16790693	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	22032731	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21785460	CNVD

Chromatin state (count:357 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:15018400-15029200	Weak transcription	Fetal Muscle Trunk	muscle
2	chr6:15022200-15031800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
3	chr6:15022400-15032600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
4	chr6:15024000-15037000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
5	chr6:15026600-15027200	Enhancers	Gastric	stomach
6	chr6:15026800-15028000	Enhancers	HepG2	liver
7	chr6:15027000-15027200	Enhancers	Fetal Thymus	thymus
8	chr6:15027000-15027200	Flanking Active TSS	Stomach Smooth Muscle	stomach
9	chr6:15027000-15027400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
10	chr6:15027000-15027400	Enhancers	Breast Myoepithelial Primary Cells	Breast
11	chr6:15027000-15027400	Enhancers	Colon Smooth Muscle	Colon
12	chr6:15027000-15027400	Enhancers	Fetal Kidney	kidney
13	chr6:15027000-15027400	Enhancers	Right Atrium	heart
14	chr6:15027000-15027400	Enhancers	Skeletal Muscle Male	skeletal muscle
15	chr6:15027000-15027600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
16	chr6:15027000-15027600	Enhancers	Aorta	Aorta
17	chr6:15027000-15027600	Enhancers	Duodenum Smooth Muscle	Duodenum
18	chr6:15027000-15027600	Enhancers	Fetal Muscle Leg	muscle
19	chr6:15027000-15027600	Enhancers	Stomach Mucosa	stomach
20	chr6:15027000-15027600	Flanking Active TSS	A549	lung
21	chr6:15027000-15027600	Enhancers	Osteobl	bone
22	chr6:15027000-15027800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
23	chr6:15027000-15027800	Enhancers	Liver	Liver
24	chr6:15027000-15027800	Enhancers	Skeletal Muscle Female	skeletal muscle
25	chr6:15027200-15027800	Enhancers	Stomach Smooth Muscle	stomach
26	chr6:15027200-15029000	Weak transcription	Fetal Thymus	thymus
27	chr6:15027400-15029200	Weak transcription	Skeletal Muscle Male	skeletal muscle
28	chr6:15027400-15036800	Weak transcription	Right Atrium	heart
29	chr6:15027400-15037000	Weak transcription	Fetal Kidney	kidney
30	chr6:15027600-15027800	Active TSS	A549	lung
31	chr6:15027600-15028000	Weak transcription	Fetal Muscle Leg	muscle
32	chr6:15028000-15028200	Enhancers	Fetal Muscle Leg	muscle
33	chr6:15028200-15029200	Weak transcription	Fetal Muscle Leg	muscle
34	chr6:15029000-15029800	Enhancers	GM12878-XiMat	blood
35	chr6:15029000-15034800	Enhancers	Fetal Thymus	thymus
36	chr6:15029200-15029400	Enhancers	Fetal Muscle Trunk	muscle
37	chr6:15029200-15029400	Enhancers	Skeletal Muscle Male	skeletal muscle
38	chr6:15029200-15029600	Enhancers	Fetal Muscle Leg	muscle
39	chr6:15029200-15029600	Enhancers	Thymus	Thymus
40	chr6:15029600-15031200	Weak transcription	Thymus	Thymus
41	chr6:15030400-15030600	ZNF genes & repeats	iPS-20b Cell Line	embryonic stem cell
42	chr6:15030600-15037200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
43	chr6:15031200-15033200	Enhancers	Thymus	Thymus
44	chr6:15031800-15032000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
45	chr6:15031800-15032400	Enhancers	Primary T helper cells PMA-I stimulated	--
46	chr6:15032000-15032400	Enhancers	Primary T cells from cord blood	blood
47	chr6:15032000-15039000	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
48	chr6:15032200-15032400	Enhancers	H9 Cell Line	embryonic stem cell
49	chr6:15032400-15033200	Weak transcription	H9 Cell Line	embryonic stem cell
50	chr6:15032400-15033600	Weak transcription	Primary T helper cells PMA-I stimulated	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links